特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
599244

コレラワクチンの世界市場:2018年~2022年

Global Cholera Vaccines Market 2018-2022

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 103 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
コレラワクチンの世界市場:2018年~2022年
出版日: 2017年12月27日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 103 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

コレラワクチンについて

コレラワクチン市場は、著名な企業がほとんど存在しないため、集中しているようです。市場の主要ベンダーは、世界中の価格とプレゼンスに基づいて競争しています。豊富なパイプライン、戦略的パートナーシップ、および運営基盤の存在は、コレラワクチン製造業者の主要競争要因です。コレラワクチンは、Shanchol、DUKORAL、およびVaxchora の3種類の製品に分けることができます。 Shancholセグメントは、コレラワクチン市場の主要シェアを占めていました。コレラは、コンゴ、イエメン、南スーダン、モザンビーク、ハイチなどの国では非常に一般的であり、Shanchol は特に6歳未満の子供に長期的な保護を提供するため、こうした国々は このワクチンを主に採用しています。

Technavioのアナリストは、2018年から2222年に世界のコレラワクチン市場が9.56%のCAGRで成長すると予測しています。

当レポートでは、世界のコレラワクチン市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 イントロダクション

  • 市場概要

第5章 市場状況

  • 市場の生態系
  • 市場特性
  • 市場セグメンテーション分析

第6章 市場規模

  • 市場の定義
  • 市場規模:2017年
  • 市場規模および予測:2017-2022年

第7章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市場状況

第8章 パイプラインの風景

第9章 市場セグメンテーション:製品別

  • 概要
  • 比較:製品別
  • Shanchol
  • DUKORAL
  • Vaxchora
  • 市場機会:製品別

第10章 市場セグメンテーション:地域別

  • 概要
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 主な先進国
  • 市場機会

第11章 意思決定の枠組み

第12章 成長要因と課題

  • 市場の課題

第13章 市場動向

  • 官民のイニシアチブの増加
  • 途上国に焦点

第14章 ベンダー情勢

  • 概要
  • 創造的破壊
  • 競合情勢

第15章 ベンダー分析

  • 対象ベンダー
  • ベンダーの分類
  • ベンダーの市場ポジショニング
  • PaxVax
  • Sanofi
  • Valneva

第16章 付録

  • 略語リスト
図表
  • Exhibit 01: Cholera: Overview
  • Exhibit 02: Severe form of cholera
  • Exhibit 03: Major cholera outbreaks 2010-2017
  • Exhibit 04: Parent market
  • Exhibit 05: Market characteristics
  • Exhibit 06: Global cholera vaccines market: Segmentation
  • Exhibit 07: Market definition: Inclusions and exclusions checklist
  • Exhibit 08: Market size 2017
  • Exhibit 09: Validation techniques employed for market sizing 2017
  • Exhibit 10: Global cholera vaccines market 2017-2022 ($ millions)
  • Exhibit 11: Global cholera vaccines market: Year-over-year growth 2018-2022 (%)
  • Exhibit 12: Five forces analysis 2017
  • Exhibit 13: Five forces analysis 2022
  • Exhibit 14: Bargaining power of buyers
  • Exhibit 15: Bargaining power of suppliers
  • Exhibit 16: Threat of new entrants
  • Exhibit 17: Threat of substitutes
  • Exhibit 18: Threat of rivalry
  • Exhibit 19: Market condition 2017
  • Exhibit 20: Pipeline landscape by sponsors or collaborators
  • Exhibit 21: Key clinical trials
  • Exhibit 22: Global cholera vaccines market: Segmentation by product 2017-2022 (% share)
  • Exhibit 23: Comparison by product
  • Exhibit 24: Description of Shanchol
  • Exhibit 25: Global Shanchol market 2017-2022 ($ millions)
  • Exhibit 26: Global Shanchol market: Year-over-year growth 2018-2022 (%)
  • Exhibit 27: Description of DUKORAL
  • Exhibit 28: Global DUKORAL market 2017-2022 ($ millions)
  • Exhibit 29: Global DUKORAL market: Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Global Vaxchora market 2017-2022 ($ millions)
  • Exhibit 31: Global Vaxchora market: Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Market opportunity by product
  • Exhibit 33: Global cholera vaccines market: Segmentation by geography 2017-2022 (% share)
  • Exhibit 34: Regional comparison
  • Exhibit 35: Cholera vaccines market in Americas 2017-2022 ($ millions)
  • Exhibit 36: Cholera vaccines market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Cholera vaccines market 2017-2022 ($ millions)
  • Exhibit 38: Cholera vaccines market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 39: Cholera vaccines market in APAC 2017-2022 ($ millions)
  • Exhibit 40: Cholera vaccines market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 41: Key leading countries: Prevalence of cholera
  • Exhibit 42: Market opportunity
  • Exhibit 43: Countries with high proportion of population without sanitation 2014
  • Exhibit 44: Number of departures from US to Asia 2012-2015
  • Exhibit 45: Departures to top Asian countries from US 2015
  • Exhibit 46: Initiatives to prevent and manage cholera
  • Exhibit 47: Vendor landscape
  • Exhibit 48: Landscape disruption
  • Exhibit 49: Competitive structure analysis
  • Exhibit 50: Vendors covered
  • Exhibit 51: Vendor classification
  • Exhibit 52: Market positioning of vendors
  • Exhibit 53: PaxVax: Overview
  • Exhibit 54: PaxVax: Business segments
  • Exhibit 55: PaxVax: Organizational developments
  • Exhibit 56: PaxVax: Geographic focus
  • Exhibit 57: PaxVax: Segment focus
  • Exhibit 58: PaxVax: Key offerings
  • Exhibit 59: PaxVax: Key customers
  • Exhibit 60: Sanofi: Overview
  • Exhibit 61: Sanofi: Business segments
  • Exhibit 62: Sanofi: Organizational developments
  • Exhibit 63: Sanofi: Geographic focus
  • Exhibit 64: Sanofi: Segment focus
  • Exhibit 65: Sanofi: Key offerings
  • Exhibit 66: Sanofi: Key customers
  • Exhibit 67: Valneva: Overview
  • Exhibit 68: Valneva: Business segments
  • Exhibit 69: Valneva: Organizational developments
  • Exhibit 70: Valneva: Geographic focus
  • Exhibit 71: Valneva: Segment focus
  • Exhibit 72: Valneva: Key offerings
  • Exhibit 73: Valneva: Key customers
目次
Product Code: IRTNTR20386

About Cholera Vaccines

The cholera vaccines market appears to be concentrated due to the presence of few established players. The major vendors in the market compete based on pricing and presence across the world. The presence of a rich pipeline, strategic partnerships, and operational base are the other major competitive factors among cholera vaccine manufacturers. Cholera vaccines can be segmented into three product types which includes Shanchol, DUKORAL, and Vaxchora. Shanchol segment accounted for the major share of the cholera vaccines market. Cholera is very common in countries such as Congo, Yemen, South Sudan, Mozambique, and Haiti and these countries are the major adopters of Shanchol since this vaccine provides better long-term protection for children especially under the age of six.

Technavio's analysts forecast the global cholera vaccines market to grow at a CAGR of 9.56% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global cholera vaccines market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of cholera vaccines.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cholera Vaccines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • PaxVax
  • Sanofi
  • Valneva

Market driver

  • Lack of proper sanitation and consumption of contaminated food
  • For a full, detailed list, view our report

Market trend

  • Increasing number of public-private initiatives
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: PIPELINE LANDSCAPE

PART 09: MARKET SEGMENTATION BY PRODUCT

  • Overview
  • Comparison by product
  • Shanchol
  • DUKORAL
  • Vaxchora
  • Market opportunity by product

PART 10: SEGMENTATION BY GEOGRAPHY

  • Overview
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market challenges

PART 13: MARKET TRENDS

  • Increasing number of public-private initiatives
  • Focus on developing countries

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • PaxVax
  • Sanofi
  • Valneva

PART 16: APPENDIX

  • List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.